PHARMACIST STEVE

Patients with opioid use disorder could see some of the biggest benefits of new CMS changes. The new rules would no longer require patients seeking opioid addiction treatment to appear on video. By allowing audio-only telehealth visits, patients would not feel the pressure to secure a space solely for telehealth services.

Part of assessing OUD patients is monitoring their appearance and mannerisms as a way to monitor medication adherence. Jittery patients can suggest withdrawal. With this promote individualized OUD treatment?

I made this post just yesterday 

QOL EQUITY: Homeostasis of the human body/biological systems

And the above statement showed up on a website – not CMS – and it would appear that there seems to be another divergent of the EQUITY between these two “disabled communities”.  Both of these communities rely on being prescribed CONTROLLED SUBSTANCES to help those in the community help manage their subjective diseases.

And then four days ago the DEA published this –

DEA looking for comments on their proposed opiate production quotas

Is it just me, or does it seem strange that CMS is making it EASIER for those in the substance abuse community to get appropriate treatment… including that there is no MME daily limits to the controlled substance that they can be provided…. while at the same time…  CMS & DEA is seeking ways & means to make appropriate therapy harder to get for those in the chronic pain community ?

This administration seem to promote EQUITY for every group… but… did CMS & DEA not get that memo ?

Filed under: General Problems